| Код ТН ВЭД | 572990 |
Как аккредитованный завод по производству биомедицинских кополимеров LACTEL 85:15 DL-PLG (B6006-1), мы соблюдаем строгие протоколы качества - каждая партия подвергается строгим испытаниям для обеспечения последовательных стандартов эффективности и безопасности.
| Упаковка | |
| Доставка | |
| Хранение |
Конкурентоспособные цены на биомедицинский кополимер LACTEL 85:15 DL-PLG (B6006-1), которые соответствуют вашему бюджету - гибкие условия и индивидуальные котировки для каждого заказа.
Для получения образцов, цен или более подробной информации свяжитесь с нами по адресу +8618136850665 или отправить по почте admin@ascent-chem.com.
Мы ответим вам как можно скорее.
Телефон: +8618136850665
Электронная почта: admin@ascent-chem.com
Гибкие условия оплаты, конкурентоспособные цены, первоклассное обслуживание — обращайтесь прямо сейчас!
LACTEL 85:15 DL-PLG (B6006-1) is an amorphous poly(DL-lactide-co-glycolide) copolymer with a nominal 85:15 molar ratio of DL-lactide to glycolide. The B6006-1 designation corresponds to an acid-terminated polymer with an inherent viscosity release band of 0.55–0.75 dL/g measured in chloroform at 30°C and 0.1% w/v. Because the DL-lactide repeat units suppress crystalline packing, the copolymer exhibits a single glass transition commonly observed between 45°C and 50°C by differential scanning calorimetry at 10°C/min under nitrogen. The polymer is soluble in dichloromethane, chloroform, tetrahydrofuran, and ethyl acetate; it is insoluble in water, ethanol, and aliphatic hydrocarbons. This solubility profile supports solvent-based microsphere and implant manufacturing while limiting premature aqueous precipitation.
Processing limits follow from the amorphous thermal profile and the acid end-group functionality. Melt processing below the glass transition is impractical because flow is insufficient; above approximately 120°C, hydrolytic and thermal chain scission compete with the viscosity reduction needed for shaping. In a twin-screw compounding configuration with an L/D ratio of 40:1, barrel zones are typically maintained between 85°C and 120°C. Residual moisture is the primary process conflict at these temperatures. Pre-drying under vacuum at 25°C for 24–48 h reduces water content before melt processing, and an in-line Karl Fischer check below 0.2% w/w water reduces autocatalytic chain cleavage during extrusion. Screw speed is adjusted so that the specific mechanical energy does not reduce inherent viscosity by more than 10% in a single pass.
An 85:15 DL-PLG degrades more slowly than a 50:50 DL-PLG because lower glycolide content reduces hydrophilicity and the number density of fast-cleaving glycolate ester sites. Water uptake in 85:15 DL-PLG is lower than in 50:50 and 75:25 grades, delaying acid accumulation inside thick specimens. Compared with poly(L-lactide), the DL-lactide component removes crystallinity; the resulting amorphous matrix distributes drug more uniformly but has lower tensile modulus and no crystalline load-bearing skeleton. Compared with an ester-terminated 85:15 DL-PLG of equivalent inherent viscosity, the acid-terminated B6006-1 is more hydrophilic and hydrolyzes faster in the initial degradation phase. This difference may be used to tune early release from microspheres or to reduce the induction period before bulk erosion begins.
| Variable | 50:50 DL-PLG acid-terminated | 75:25 DL-PLG acid-terminated | 85:15 DL-PLG acid-terminated B6006-1 | 85:15 DL-PLG ester-terminated |
|---|---|---|---|---|
| Glycolide content | 50 mol% | 25 mol% | 15 mol% | 15 mol% |
| Amorphous glass transition | 40–45°C | 44–48°C | 45–50°C | 45–50°C |
| Relative water uptake | highest | intermediate | lower | lowest |
| Relative erosion rate | fastest | intermediate | slower | slowest |
| End-group autocatalysis | present | present | present | absent |
Solvent-based microsphere processes commonly dissolve B6006-1 in dichloromethane at concentrations between 5% and 20% w/w. The organic phase is emulsified into an aqueous poly(vinyl alcohol) phase under high shear. Process controls should track kinematic viscosity of the organic phase at 25°C and residual dichloromethane in the final microspheres by USP <467>. High-shear rotor-stator mixing reduces mean droplet size, but excessive energy input can narrow molecular weight distribution only if local heating is uncontrolled. Since the polymer is acid-terminated, early water contact during solvent evaporation can initiate surface hydrolysis and alter the particle morphology.
In vitro degradation studies for B6006-1 are generally conducted in phosphate-buffered saline at 37°C and pH 7.4. A single in vitro erosion time is not an intrinsic material property; it is geometry-dependent and varies with surface-area-to-volume ratio, medium replacement interval, and specimen processing. Studies should therefore report the medium volume-to-specimen mass ratio and the molecular weight measurement method, preferably gel permeation chromatography with polystyrene calibration. Published degradation profiles for 85:15 DL-PLG show slower molecular weight loss than 50:50 at comparable inherent viscosity and end-group chemistry, but absolute slopes differ between laboratories.
Moisture is the dominant process conflict for melt-processed B6006-1. The polymer is supplied with controlled water content, but ambient exposure above 60% relative humidity can increase surface moisture rapidly. Pre-drying at 25°C under vacuum below 10 mbar for 24–48 h is used before extrusion; dry nitrogen with a dew point below -40°C is acceptable if the polymer is spread in thin trays. In injection molding, a reciprocating screw with a low-compression ratio is preferred because high shear heating accelerates IV loss. Mold temperatures below 20°C are usually unnecessary for ejection because the amorphous copolymer softens near 45°C. Published data for large-scale injection molding of this specific grade is limited; development batches therefore require in-mold pressure monitoring and post-molding inherent viscosity measurement.
Residual monomer content is a critical specification because lactide and glycolide monomers hydrolyze and can reduce local pH within a closed device. The manufacturer controls residual monomer by gas chromatography or high-performance liquid chromatography; pharmaceutical users may set an internal limit below 1.0% total residual monomers. Residual tin from stannous octoate catalyst is monitored by elemental analysis. Accepted levels depend on the route of administration and the applicable pharmacopoeial monograph. Incompatible additives include strong bases, strong oxidizers, and amine-bearing compounds that accelerate ester hydrolysis through nucleophilic attack or pH shifts.
Certificates of analysis for B6006-1 typically list nominal lactide:glycolide ratio, inherent viscosity, acid number, residual monomer, and residual solvent. The inherent viscosity band of 0.55–0.75 dL/g is a release control because it influences both processability and erosion rate. A lower-IV lot may dissolve and atomize more easily but will degrade more rapidly; a higher-IV lot may require higher solvent loading and longer processing. Acid number is determined by potentiometric titration and confirms terminal carboxylic acid group concentration. This value is not equivalent to residual acidity from monomer and must be considered in stability studies.
| Parameter | Method or condition | Typical band or reference |
|---|---|---|
| Inherent viscosity | Chloroform, 30°C, 0.1% w/v | 0.55–0.75 dL/g |
| Glass transition | DSC, 10°C/min, nitrogen | 45–50°C |
| Lactide:glycolide ratio | 1H NMR | Nominal 85:15 |
| Residual solvents | USP <467>, Ph. Eur. 2.4.24 | ICH Q3C limits |
| Water content | Karl Fischer, USP <921> | <0.5% w/w at release |
| Biocompatibility | ISO 10993-1:2018 | Device-specific endpoints |
The specification boundaries for B6006-1 reflect a manufacturer quality system aligned to ISO 13485:2016. The polymer is supplied as a raw material for further processing, not as a final device. Responsibility for sterilization validation, packaging, and final device performance remains with the device manufacturer. Gamma irradiation can reduce inherent viscosity through chain scission; dose mapping and post-sterilization IV measurement are required when terminal sterilization is selected. Ethylene oxide is generally unsuitable for this moisture-sensitive material unless extended aeration cycles are qualified and residual ethylene oxide content is verified by gas chromatography.
Mechanical property testing of solvent-cast or melt-pressed films is commonly performed according to ASTM D882-18 for thin films and ASTM D638-14 for molded specimens. Because the glass transition lies near physiological temperature, tensile modulus and elongation are highly temperature-dependent. Testing at 37°C in phosphate-buffered saline requires specimen equilibration and temperature-controlled grips. Results from dried specimens at 23°C do not predict in vivo load-bearing behavior. For implantable devices, degradation product evaluation and local tissue response fall under ISO 10993-1:2018 and related parts, with the final test program determined by device composition and body contact duration.
B6006-1 is supported by a Type IV drug master file for pharmaceutical applications. The file typically contains synthesis route, residual solvent, residual monomer, heavy metals, and stability data. Incoming-release testing at the device manufacturer is necessary because polymer batch variance can alter microsphere particle size distribution, organic-phase viscosity, and in vivo release. Critical incoming tests include inherent viscosity, acid number, residual monomer, and water content. When substituting B6006-1 for another supplier-grade 85:15 PLGA, equivalence must be demonstrated on the same solvent and temperature basis because apparent inherent viscosity depends on solvent, concentration, and end-group chemistry.